CWM, LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
CWM, LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,805
+39.3%
40,130
+43.2%
0.02%
+41.7%
Q2 2023$2,014
+100600.0%
28,026
+93320.0%
0.01%
Q1 2023$20.0%300.0%0.00%
Q4 2022$2
-99.8%
30
+50.0%
0.00%
Q3 2022$1,0000.0%200.0%0.00%
Q2 2022$1,0000.0%20
-31.0%
0.00%
Q1 2022$1,000
-66.7%
29
-68.1%
0.00%
Q4 2021$3,000
-100.0%
91
-99.9%
0.00%
-100.0%
Q2 2021$6,167,0000.0%91,4170.0%0.05%0.0%
Q1 2021$6,167,0000.0%91,4170.0%0.05%0.0%
Q4 2020$6,167,0000.0%91,4170.0%0.05%0.0%
Q3 2020$6,167,0000.0%91,4170.0%0.05%0.0%
Q2 2020$6,167,0000.0%91,4170.0%0.05%0.0%
Q1 2020$6,167,0000.0%91,4170.0%0.05%0.0%
Q4 2019$6,167,0000.0%91,4170.0%0.05%0.0%
Q3 2019$6,167,0000.0%91,4170.0%0.05%0.0%
Q2 2019$6,167,0000.0%91,4170.0%0.05%0.0%
Q1 2019$6,167,00091,4170.05%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders